Maternal serologic screening for toxoplasmosis

被引:34
作者
Pinard, JA
Leslie, NS
Irvine, PJ
机构
[1] W Virginia Univ, Sch Nursing, HSC, Morgantown, WV 26506 USA
[2] Summersville Mem Hosp, Summersville, WV USA
[3] W Virginia Univ, Family Nurse Practitioner Program, Morgantown, WV 26506 USA
[4] Valley Veterinarians, Teays Valley, WV USA
关键词
toxoplasmosis; serologic screening; T; gondii;
D O I
10.1016/S1526-9523(03)00279-4
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Congenital toxoplasmosis is a rare, but potentially serious, problem during pregnancy. Toxoplasmosis is caused by a protozoal parasite that can be found in warm-blooded animals (including humans); dried cat feces, contaminated soil, or contaminated water; and raw or undercooked meat containing infective tissue cysts. Although cats play a role in the epidemiology of the disease, there is no statistical correlation between toxoplasmosis infection and cat ownership. Toxoplasmosis can be transmitted to the fetus in utero through transplacental transmission. Both the incidence of placental transmission and severity of congenital disease depend on gestational age at which maternal seroconversion occurs. Although transmission rates from mother to fetus tend to be low early in pregnancy, fetal disease severity is highest when the fetus is infected early in gestation. Serological tests to determine maternal seroconversion are available, but their use can pose ethical and practical dilemmas. Universal maternal screening is not currently warranted in the United States because disease prevalence is low. (C) 2003 by the American College of Nurse-Midwives.
引用
收藏
页码:308 / 316
页数:9
相关论文
共 31 条
[1]  
*AM AC FAM PHYS, 2001, TOX PREGN
[2]  
*AM COLL OBST GYN, 2000, PER VIR PAR INF
[3]  
[Anonymous], 2000, MMWR MORBMORTAL WKLY
[4]   Prenatal screening for toxoplasmosis [J].
Bader, TJ ;
Macones, GA ;
Asch, DA .
OBSTETRICS AND GYNECOLOGY, 1997, 90 (03) :457-464
[5]  
*CTR DIS CONTR PRE, 2003, PAR DIS INF
[6]   PRENATAL MANAGEMENT OF 746 PREGNANCIES AT RISK FOR CONGENITAL TOXOPLASMOSIS [J].
DAFFOS, F ;
FORESTIER, F ;
CAPELLAPAVLOVSKY, M ;
THULLIEZ, P ;
AUFRANT, C ;
VALENTI, D ;
COX, WL .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (05) :271-275
[7]  
*DIV PAR DIS, 2001, TOX GOND LIF CYCL
[8]   Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling [J].
Dunn, D ;
Wallon, M ;
Peyron, F ;
Petersen, E ;
Peckham, C ;
Gilbert, R .
LANCET, 1999, 353 (9167) :1829-1833
[9]  
*FDA, 1997, FDA P UBL HLTH ADV L
[10]   EVALUATION OF THE POSSIBILITIES FOR PREVENTING CONGENITAL TOXOPLASMOSIS [J].
FOULON, W ;
NAESSENS, A ;
DERDE, MP .
AMERICAN JOURNAL OF PERINATOLOGY, 1994, 11 (01) :57-62